In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List

Liquid Biopsy Surveillance and Early Detection Summit

Nov 16, 2022 - 07:30 AM - Nov 17, 04:00 PM
Hanson Wade
Hilton Boston Back Bay
40, Dalton St

ZIP: 02115
Phone: +16174554188

Ticket Price: USD 0.50 - USD 3599.00

In the wake of new FDA guidance and exciting MRD partnership announcements between Grail and AstraZeneca, Amgen and Bristol Myers Squibb the liquid biopsy industry is experiencing a paradigm shift. Touted as having the potential to transform clinical practice as we know it, technical progress and mounting investment in premetastatic applications are creating huge industry-wide excitement for liquid biopsy-based screening and surveillance for novel precision drug development.

With technology maturity on the near horizon, the inaugural Liquid Biopsy Surveillance and Early Detection Summit is your only dedicated platform providing much-needed clarity on the industry's emerging assays increasingly opening the doors to novel trial design and better patient outcomes.

As drug and diagnostic developers look to realize the commercial impact of early detection and MRD while shifting pipelines from the metastatic setting, here lies your best opportunity to harness game-changing technologies to define leading stratification, surrogate endpoint, and regulatory strategies - accelerating the delivery of breakthrough therapies into the clinic.

Providing a path forward for early detection and surveillance to become a widespread patient reality, unite with 80+ Translational, Biomarker, Clinical, Regulatory, Precision Medicine, Medical Affairs and Diagnostic experts at your only forum prioritizing liquid biopsy applications for earlier intervention.

Ensure you and your team stay ahead of the curve with unmissable intelligence November!

Tickets: https://go.evvnt.com/1315351-2?pid=1052
Brochure: https://go.evvnt.com/1315351-3?pid=1052

Drug Developers and Academics Conference Pass: USD 0.50,
Commercial Vendors Conference Pass: USD 3599.00,
Technical Vendors Conference Pass: USD 2599.00

Speaker Details

Aadel Chaudhuri, Assistant Professor of Radiation Oncology, Washington University School of Medicine, Arnab Basu, Medical Oncologist, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Carl Barrett, Vice President, Translational Science, Oncology R and D, AstraZeneca, Dave Cescon, Clinician Scientist, Princess Margaret Cancer Centre, Diana Merino, Vega Director, Oncology Translational Medicine Strategy and Portfolio, AstraZeneca, Gary Kelloff, Special Advisor, Cancer Imaging Program, National Cancer Institute, Islam Mohamed, Clinical Assistant Professor, University of British Columbia, Jean-François Martini, Executive Director, Translational Oncology Lead, Global Product Development, Oncology, Pfizer, Johan Skog, Chief Scientific Officer and Vice President, ExosomeDx, a Bio-Techne Brand, Leah Fine, Senior Director, Centers of Excellence Program, GO2 Foundation for Lung Cancer, Lourdes Barrera, Executive Director, Global Medical Affairs, Oncology, Precision Medicine, Merck, Matt Davis, Senior Director, Molecular Biology and Sequencing, Gritstone bio, Mohan Bolisetty, WW Medical Lead, Bristol Myers Squibb, Panna Sharma, Chief Executive Officer, President and Board Member, Lantern Pharma, Pashtoon Kasi, Assistant Professor of Medicine, Weill Cornell Medical College, Stephen Ezell, Vice President, Global Innovation Policy, Information Technology and Innovation Foundation, Zheng Feng, Director, Global Clinical Biomarkers and Companion Diagnostics, Global Development, EMD Serono

Event Categories
Keywords: conference


Events Calendar

30 31 1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 1 2 3

Event Location


VIP Life Time Subscription to our Newsletters!